Development code · Small Molecule
ALKS 2680
ALKS 2680 is a development code for Alixorexton, developed by Alkermes plc.
- Status
- Phase 3 for Narcolepsy
- Mechanism
- OX2R Agonist
- Developer
- Alkermes plc
Programs
- Alixorexton for NarcolepsyPhase 3Active
- Alixorexton for Idiopathic HypersomniaPhase 2Recruiting
Also known as
- Alixorexton
- 2648347-56-0